PALATIN TECHNOLOGIES INC financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic.
Latest period: Q4 2025.
-
Symbol
-
PTNT, PTN on NYSE
-
Location
-
Cranbury, NJ
-
Fiscal year end
-
30 June
-
Latest financial report
-
17 Feb 2026
Quick Takeaways
- PTNT - PALATIN TECHNOLOGIES INC financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q4 2025.
- Headline metric: Return On Equity -379%.
What Changed
- Return On Equity YoY change: <span class="text-red-600">-225%</span>.
- Most recent SEC facts end date: 13 Feb 2026.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Official SEC Source
Based on latest 10-Q/10-K
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original Filing
Latest SEC snapshot (2026-02-13) highlights Return On Equity -378.7%, Return On Assets -86.6%, and Operating Margin -8403.8%.
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
33.5/100
Weak
Confidence medium
Return On Equity
-379%
Metric score 0.0/100
Return On Assets
-87%
Metric score 0.0/100
Financial Health
- Current Ratio
- 2.76x
- Quick Ratio
- 2.54x
- Debt to Equity
- 47.03x
Strengths
Current Ratio and NetIncomeLoss YoY
Watchpoints
Return On Equity, Return On Assets, and Operating Margin
Key metrics snapshot
Return On Equity
-379%
YoY: -225%
Industry median:
-43%
(n=675)
View history
Return On Assets
-87%
YoY: -71%
Industry median:
-47%
(n=673)
View history
Operating Margin
-8404%
YoY:
Industry median:
-121%
(n=298)
View history
Current Ratio
2.76x
YoY: +618%
Industry median:
3.39x
(n=667)
View history
Quick Ratio
2.54x
YoY:
Industry median:
1.51x
(n=289)
View history
Debt-to-equity
47.03x
YoY: -1495%
Industry median:
0.26x
(n=530)
View history
NetIncomeLoss YoY
64%
YoY:
Industry median:
-0.93%
(n=641)
View history
Profitability
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Return On Equity
|
-379%
|
-225%
|
-43%
(n=675)
|
Q4 2025
|
Q2 2026
|
%
|
|
Return On Assets
|
-87%
|
-71%
|
-47%
(n=673)
|
Q4 2025
|
Q2 2026
|
%
|
|
Operating Margin
|
-8404%
|
|
-121%
(n=298)
|
Q4 2025
|
|
%
|
Financial Health
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Current Ratio
|
2.76x
|
+618%
|
3.39x
(n=667)
|
Q4 2025
|
Q2 2026
|
x
|
|
Quick Ratio
|
2.54x
|
|
1.51x
(n=289)
|
Q4 2025
|
|
x
|
|
Debt-to-equity
|
47.03x
|
-1495%
|
0.26x
(n=530)
|
Q4 2025
|
Q2 2026
|
x
|
Growth
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
NetIncomeLoss YoY
|
64%
|
|
-0.93%
(n=641)
|
Q4 2025
|
Q2 2026
|
%
|
Share Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Entity Common Stock, Shares Outstanding
|
1,772,199
|
-93%
|
Q4 2025
|
Q2 2026
|
shares
|
|
Common Stock, Shares, Outstanding
|
1,757,199
|
-93%
|
Q4 2025
|
Q2 2026
|
shares
|
|
Common Stock, Value, Issued
|
$17,572
|
-93%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Weighted Average Number of Shares Outstanding, Basic
|
2,539,632
|
+515%
|
Q4 2025
|
Q2 2026
|
shares
|
|
Weighted Average Number of Shares Outstanding, Diluted
|
2,539,632
|
+515%
|
Q4 2025
|
Q2 2026
|
shares
|
Additional Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Revenue from Contract with Customer, Excluding Assessed Tax
|
$116,036
|
|
Q4 2025
|
Q2 2026
|
USD
|
|
Research and Development Expense
|
$12,570,794
|
-40%
|
Q4 2025
|
Q2 2026
|
USD
|
|
General and Administrative Expense
|
$3,124,817
|
+86%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Operating Income (Loss)
|
$9,751,426
|
+65%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Earnings Per Share, Basic
|
-2.86
|
+52%
|
Q4 2025
|
Q2 2026
|
USD/shares
|
|
Earnings Per Share, Diluted
|
-5.12
|
+52%
|
Q4 2025
|
Q2 2026
|
USD/shares
|
|
Cash and Cash Equivalents, at Carrying Value
|
$14,476,162
|
|
Q4 2025
|
Q2 2026
|
USD
|
|
Accounts Receivable, after Allowance for Credit Loss, Current
|
$1,636,325
|
|
Q4 2025
|
Q2 2026
|
USD
|
|
Assets, Current
|
$17,467,479
|
+376%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Property, Plant and Equipment, Net
|
$113,485
|
-52%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Operating Lease, Right-of-Use Asset
|
$346,764
|
-0.25%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Assets
|
$17,927,728
|
+316%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Accounts Payable, Current
|
$5,453,080
|
-19%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Accrued Liabilities, Current
|
$659,841
|
-60%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Liabilities, Current
|
$6,332,648
|
-34%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Operating Lease, Liability, Noncurrent
|
$129,061
|
+29%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Liabilities
|
$6,461,709
|
-40%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Retained Earnings (Accumulated Deficit)
|
$461,660,226
|
-2.1%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Stockholders' Equity Attributable to Parent
|
$11,466,019
|
|
Q4 2025
|
Q2 2026
|
USD
|
|
Liabilities and Equity
|
$17,927,728
|
+316%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Common Stock, Shares Authorized
|
300,000,000
|
0%
|
Q4 2025
|
Q2 2026
|
shares
|
|
Common Stock, Shares, Issued
|
1,757,199
|
-93%
|
Q4 2025
|
Q2 2026
|
shares
|
|
Common Stock, Par or Stated Value Per Share
|
0.01
|
0%
|
Q4 2025
|
Q2 2026
|
USD/shares
|
|
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
|
$14,476,162
|
+324%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Operating Lease, Liability
|
$248,718
|
|
Q4 2025
|
Q2 2026
|
USD
|
|
Depreciation
|
$14,388
|
-80%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Operating Lease, Liability, Current
|
$219,727
|
-15%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Preferred Stock, Shares Authorized
|
10,000,000
|
0%
|
Q4 2025
|
Q2 2026
|
shares
|
|
Additional Paid in Capital
|
$473,108,599
|
+6.2%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Preferred Stock, Par or Stated Value Per Share
|
0.01
|
0%
|
Q4 2025
|
Q2 2026
|
USD/shares
|
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric |
Weight |
V1 threshold |
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY
Explore related SEC datasets